SG10201709806VA - Hemagglutinin polypeptides, and reagents and methods relating thereto - Google Patents

Hemagglutinin polypeptides, and reagents and methods relating thereto

Info

Publication number
SG10201709806VA
SG10201709806VA SG10201709806VA SG10201709806VA SG10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA
Authority
SG
Singapore
Prior art keywords
reagents
methods relating
hemagglutinin polypeptides
hemagglutinin
polypeptides
Prior art date
Application number
SG10201709806VA
Other languages
English (en)
Inventor
Kannan Tharakaraman
Karthik Viswanathan
Rahul Raman
Ram Sasisekharan
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of SG10201709806VA publication Critical patent/SG10201709806VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG10201709806VA 2010-10-04 2011-10-04 Hemagglutinin polypeptides, and reagents and methods relating thereto SG10201709806VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38963910P 2010-10-04 2010-10-04

Publications (1)

Publication Number Publication Date
SG10201709806VA true SG10201709806VA (en) 2017-12-28

Family

ID=44860519

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013024617A SG189236A1 (en) 2010-10-04 2011-10-04 Hemagglutinin polypeptides, and reagents and methods relating thereto
SG10201709806VA SG10201709806VA (en) 2010-10-04 2011-10-04 Hemagglutinin polypeptides, and reagents and methods relating thereto

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013024617A SG189236A1 (en) 2010-10-04 2011-10-04 Hemagglutinin polypeptides, and reagents and methods relating thereto

Country Status (10)

Country Link
US (2) US10226527B2 (fr)
EP (1) EP2624864B1 (fr)
JP (2) JP6029586B2 (fr)
CN (1) CN103328002B (fr)
AU (1) AU2011312178B2 (fr)
BR (1) BR112013007946B1 (fr)
CA (1) CA2813078A1 (fr)
RU (1) RU2663718C2 (fr)
SG (2) SG189236A1 (fr)
WO (1) WO2012047941A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103328002B (zh) 2010-10-04 2020-01-14 麻省理工学院 血球凝集素多肽以及与其相关的试剂和方法
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
TWI700368B (zh) 2011-09-30 2020-08-01 苜蓿股份有限公司 增加植物類病毒顆粒產率
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
EP3492101A3 (fr) 2012-05-10 2019-10-23 Massachusetts Institute Of Technology Agents de neutralisation de la grippe
CN105263954B (zh) * 2013-02-07 2019-12-03 麻省理工学院 H5流感的人类适应
US10022434B2 (en) 2013-03-15 2018-07-17 The Trustees Of The University Of Pennsylvania Influenza nucleic acid molecules and vaccines made therefrom
CN105247059B (zh) 2013-03-28 2021-07-06 莫迪卡戈公司 植物中流感样病毒颗粒的产生
US11441150B2 (en) 2014-01-10 2022-09-13 Medicago Inc. CPMV enhancer elements
WO2016100926A1 (fr) * 2014-12-19 2016-06-23 Oregon Health & Science University Co-administration synergique d'antigènes réactifs à large spectre optimisés par le calcul pour la grippe h5n1 humaine et aviaire
WO2017083627A1 (fr) 2015-11-13 2017-05-18 Visterra, Inc. Compositions et méthodes pour traiter et prévenir la grippe
EP3946613A1 (fr) 2019-03-25 2022-02-09 Visterra, Inc. Compositions et méthodes pour traiter et prévenir la grippe
CN110172452B (zh) * 2019-05-21 2021-07-06 广州医科大学 一种高致病性h7n9禽流感病毒、疫苗、检测试剂以及病毒、疫苗的制备方法
JP2022038604A (ja) 2020-08-27 2022-03-10 株式会社Subaru 車両の制御装置

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4692411A (en) 1983-09-06 1987-09-08 Ghose Rabindra N Separation of specific biological cells by a biochemical filter
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
CA1283827C (fr) 1986-12-18 1991-05-07 Giorgio Cirelli Dispositif pour l'injection de formules liquides
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5698390A (en) 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
EP0438803B1 (fr) 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccins contre le cancer et les maladies infectieuses
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5500161A (en) 1993-09-21 1996-03-19 Massachusetts Institute Of Technology And Virus Research Institute Method for making hydrophobic polymeric microparticles
WO1995024176A1 (fr) 1994-03-07 1995-09-14 Bioject, Inc. Dispositif de remplissage d'ampoule
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
AU2001268662A1 (en) 2000-06-23 2002-01-08 Wyeth Holdings Corporation Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
EP1771552B1 (fr) * 2004-05-25 2012-08-01 MedImmune Vaccines, Inc. Variantes d'hémagglutinine influenza et de neuraminidase
WO2006108226A1 (fr) 2005-04-12 2006-10-19 The University Of Queensland Systeme de delivrance d’un vaccin
US20090169576A1 (en) 2005-10-26 2009-07-02 Roberto Crea Influenza combinatorial antigen vaccine
TW200806316A (en) * 2006-02-02 2008-02-01 Globeimmune Inc Yeast-based vaccine for inducing an immune response
WO2007130330A2 (fr) 2006-05-01 2007-11-15 Technovax, Inc. Compositions de particules de type viral (vlp) polyvalentes de la grippe
WO2007130327A2 (fr) 2006-05-01 2007-11-15 Technovax, Inc. Compositions de particules de type viral (vlp) de la grippe
EP1998814A4 (fr) 2006-05-11 2010-06-16 Novavax Inc Nouveaux vaccins contre l'influenza m2
US20100143406A1 (en) 2006-06-30 2010-06-10 Gale Smith Methods of enhancing protein incorporation into virus like particles
JP2009544322A (ja) 2006-07-27 2009-12-17 リゴサイト ファーマシューティカルズ インコーポレイテッド キメラウイルス様粒子
WO2008094197A2 (fr) 2006-07-27 2008-08-07 Ligocyte Pharmaceuticals, Inc. Particules de type virus grippal chimérique
CN104278014A (zh) * 2006-08-09 2015-01-14 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
CN101553502A (zh) * 2006-08-14 2009-10-07 麻省理工学院 血球凝集素多肽和其相关试剂和方法
US20090269342A1 (en) 2006-08-14 2009-10-29 Massachusetts Institute Of Technology Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
KR20090050056A (ko) 2006-08-14 2009-05-19 메사츄세츠 인스티튜트 어브 테크놀로지 헤마글루티닌 폴리펩티드 및 시약 그리고 방법
WO2008040060A1 (fr) 2006-10-04 2008-04-10 The University Of Queensland Système d'administration de vaccin à base de vlp
US20100074916A1 (en) 2006-10-10 2010-03-25 Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Avian influenza vaccine
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
US20080233150A1 (en) 2006-11-16 2008-09-25 Gale Smith Respiratory syncytial virus-virus like particle (vlps)
BRPI0806336A2 (pt) * 2006-12-29 2011-09-06 Inst Pasteur Of Shanghai lentivìrus pseudotipado com hemaglutinina da gripe e métodos de uso
WO2008148104A1 (fr) 2007-05-25 2008-12-04 Novavax, Inc. Nouvelles vlp dérivées de cellules qui n'expriment pas une matrice virale ou une protéine du noyau
CA2615372A1 (fr) 2007-07-13 2009-01-13 Marc-Andre D'aoust Particules semblables au virus grippal a comprenant de l'hemagglutinine
JP2010533737A (ja) 2007-07-19 2010-10-28 ノババックス,インコーポレイテッド キメラ水痘帯状疱疹ウイルス−ウイルス様粒子
AU2009204345A1 (en) 2008-01-03 2009-07-16 Massachusetts Institute Of Technology Decoy influenza therapies
EP2238146A4 (fr) * 2008-01-03 2012-03-21 Massachusetts Inst Technology Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant
ES2593277T3 (es) 2008-07-18 2016-12-07 Medicago Inc. Nuevo epítopo de inmunización contra el virus de la influenza
AU2010266129B2 (en) 2009-07-02 2016-04-14 Massachusetts Institute Of Technology Compositions and methods for diagnosing and/or treating influenza infection
CN103328002B (zh) 2010-10-04 2020-01-14 麻省理工学院 血球凝集素多肽以及与其相关的试剂和方法
CN105263954B (zh) 2013-02-07 2019-12-03 麻省理工学院 H5流感的人类适应

Also Published As

Publication number Publication date
US20190142931A1 (en) 2019-05-16
CA2813078A1 (fr) 2012-04-12
WO2012047941A2 (fr) 2012-04-12
RU2663718C2 (ru) 2018-08-08
US20120213819A1 (en) 2012-08-23
JP2013543499A (ja) 2013-12-05
EP2624864B1 (fr) 2017-12-06
RU2013114424A (ru) 2014-11-20
CN103328002B (zh) 2020-01-14
JP2016094483A (ja) 2016-05-26
SG189236A1 (en) 2013-05-31
CN103328002A (zh) 2013-09-25
BR112013007946A2 (pt) 2018-04-17
BR112013007946B1 (pt) 2022-07-12
EP2624864A2 (fr) 2013-08-14
JP6143902B2 (ja) 2017-06-07
WO2012047941A3 (fr) 2013-04-11
JP6029586B2 (ja) 2016-11-24
AU2011312178A1 (en) 2013-05-02
US10226527B2 (en) 2019-03-12
AU2011312178B2 (en) 2016-05-12

Similar Documents

Publication Publication Date Title
HRP20191852T8 (hr) Polipeptidi
SG10201709806VA (en) Hemagglutinin polypeptides, and reagents and methods relating thereto
EP2713879A4 (fr) Dispositifs détecteurs d'analytes, connexions, et procédés
HK1182719A1 (en) Polypeptides
GB201115529D0 (en) Antibodies, uses and methods
GB201115280D0 (en) Antibodies, uses and methods
EP2818855A4 (fr) Élement de capteur de gaz, et capteur de gaz
EP2609416A4 (fr) Analyse de dosage à écoulement latéral
HK1202511A1 (en) Pivoting arrangement, roof element and elevator
EP2672273A4 (fr) Puce d'inspection, et ensemble puce d'inspection comportant la puce d'inspection
EP2632949A4 (fr) Anticorps spécifiques de clostridium difficile et leurs applications
ZA201405554B (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
ZA201400766B (en) Belt-conveying installatio, method for operating the same, and use thereof
EP2594281A4 (fr) Complexe insuline-lipide, son procédé de préparation et sa préparation
EP2718348A4 (fr) Systèmes, réactifs et procédés de diagnostic de production de couleur
ZA201406381B (en) Levoisovalerylspiramycin i,ii,iii,and preparations,preparations methods and uses thereof
IL225990A (en) Electrophilic reagents for monohalomethylation, preparation and use
GB201220902D0 (en) A novel reagent and method using the same
HK1198655A1 (en) High mast2-affinity polypeptides and uses thereof mast2
EP2657330A4 (fr) Outil de détection et système de détection
HK1211042A1 (en) Inflammation-enabling polypeptides and uses thereof
PL2635838T3 (pl) Element, w szczególności element zamykający
EP2752419A4 (fr) Spirobenzylamine-phosphine, son procédé de préparation et son utilisation
EP2238146A4 (fr) Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant
GB201004339D0 (en) Sequence detection assay